Expression of CPEB, GAPDH and U6snRNA in cervical and ovarian tissue during cancer development

APMIS

Volumn 117, Issue 1, 2009, Pages 53-59

  Hansen, Christina Neigaard ^a,b   Ketabi, Zohreh ^c   Rosenstierne, Maiken WorsØe ^d   Palle, Connie ^c   Boesen, Hans Christian ^e   Norrild, Bodil ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Institute of Cellular and Molecular Medicine   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cancer; CPEB; GAPDH; HPV; U6snRNA

Indexed keywords

CYTOPLASMIC POLYADENYLATION ELEMENT BINDING PROTEIN; CYTOPLASMIC POLYADENYLATION ELEMENT BINDING PROTEIN 3; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GUANOSINE; MESSENGER RNA; RNA; SMALL NUCLEAR RNA; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; OVARY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; UTERINE CERVIX CANCER; UTERINE CERVIX EPITHELIUM; WART VIRUS;

ALPHAPAPILLOMAVIRUS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; OVARIAN NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; RNA, MESSENGER; RNA, SMALL NUCLEAR; RNA-BINDING PROTEINS; TRANSCRIPTION FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 58649109596     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2008.00015.x     Document Type: Article

References (26)

1. Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol 2006 20 : 207 25.
2. Bosch FX, Manos MM, N Munoz, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst 1995 87 : 796 802.
3. Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 2000 19 : 1 5.
4. Munoz N, Castellsague X, de Gonzalez AB, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006 24S3 : S1 10.
5. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004 324 : 17 27.
6. Sathish N, Abraham P, Peedicayil A, Sridharan G, John S, Chandy G. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia. Mol Diagn 2004 8 : 57 64.
7. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007 370 : 890 907.
8. Vinther J, Rosenstierne MW, Kristiansen K, Norrild B. The 3′ region of human papillomavirus type 16 early mRNAs decrease expression. BMC Infect Dis 2005 5 : 83.
9. Glahder JA, Kristiansen K, Durand M, Norrild B. Human papillomavirus type 16 early mRNA has the ability to be regulated by cytoplasmic polyadenylation. submitted 2008.
10. Mendez R, Richter JD. Translational control by CPEB: a means to the end. Nat Rev Mol Cell Biol 2001 2 : 521 9.
11. Richter JD. CPEB: a life in translation. Trends Biochem Sci 2007 32 : 279 85.
12. Mendez R, Barnard D, Richter JD. Differential mRNA translation and meiotic progression require Cdc2-mediated CPEB destruction. EMBO J 2002 21 : 1833 44.
13. Groisman I, Ivshina M, Marin V, Kennedy NJ, Davis RJ, Richter JD. Control of cellular senescence by CPEB. Genes Dev 2006 20 : 2701 12.
14. Huang YS, Kan MC, Lin CL, Richter JD. CPEB3 and CPEB4 in neurons: analysis of RNA-binding specificity and translational control of AMPA receptor GluR2 mRNA. EMBO J 2006 25 : 4865 76.
15. Racki WJ, Richter JD. CPEB controls oocyte growth and follicle development in the mouse. Development 2006 133 : 4527 37.
16. Theis M, Si K, Kandel ER. Two previously undescribed members of the mouse CPEB family of genes and their inducible expression in the principal cell layers of the hippocampus. Proc Natl Acad Sci USA 2003 100 : 9602 7.
17. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001 25 : 402 8.
18. Remmerbach TW, Brinckmann UG, Hemprich A, Chekol M, Kuhndel K, Liebert UG. PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. J Clin Virol 2004 30 : 302 8.
19. Rondinelli RH, Epner DE, Tricoli JV. Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in late pathological stage human prostate cancer. Prostate Cancer Prostatic Dis 1997 1 : 66 72.
20. Tokunaga K, Nakamura Y, Sakata K, Fujimori K, Ohkubo M, Sawada K, et al. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res 1987 47 : 5616 9.
21. Arcari P, Martinelli R, Salvatore F. The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucleic Acids Res 1984 12 : 9179 89.
22. Scherr M, Venturini L, Battmer K, Schaller-Schoenitz M, Schaefer D, Dallmann I, et al. Lentivirus-mediated antagomir expression for specific inhibition of miRNA function. Nucleic Acids Res 2007 35 : e149.
23. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 2006 110 : 525 41.
24. de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007 7 : 453 9.
25. Kahn T, Schwarz E, zur Hausen H. Molecular cloning and characterization of the DNA of a new human papillomavirus (HPV 30) from a laryngeal carcinoma. Int J Cancer 1986 37 : 61 5.
26. Bonafe N, Gilmore-Hebert M, Folk NL, Azodi M, Zhou Y, Chambers SK. Glyceraldehyde-3-phosphate dehydrogenase binds to the AU-Rich 3′ untranslated region of colony-stimulating factor-1 (CSF-1) messenger RNA in human ovarian cancer cells: possible role in CSF-1 posttranscriptional regulation and tumor phenotype. Cancer Res 2005 65 : 3762 71.